Ironwood Pharmaceuticals, Inc.

IRWD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.36+3.07%

2026-09-18

Financials

Valuation Metrics

Ironwood Pharmaceuticals, Inc.'s Market Cap is $718M. At end of 2025 it was $547M. Ranked #2649 of 3,121 in US market (top 85%), #1129 of 1,463 on NASDAQ (top 77%), #206 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$718M	US#2,649/3,121 Sec#206/266
Revenue	$389M	US#2,364/3,121 Sec#87/266
Net Income	$130M	US#1,517/3,121 Sec#49/266
Total Assets	$285M	US#2,924/3,121 Sec#214/266
Net Assets	$-162M	US#2,978/3,121 Sec#255/266
Value
P/E	5.53x	US#64/3,121 Sec#4/266
P/S	1.84x	US#1,186/3,121 Sec#22/266
EV/EBITDA	4.29x	US#111/3,121 Sec#6/266
FCF Yield	25.85%	US#102/3,121 Sec#4/266
Profitability
ROA	45.55%	US#11/3,121 Sec#3/266
Op. Margin	60.64%	US#66/3,121 Sec#3/266
Revenue Growth	26.19%	US#496/3,121 Sec#66/266
Financial Health
Total Debt	$397M	US#1,999/3,121 Sec#72/266
FCF	$186M	US#1,429/3,121 Sec#46/266
Cash	$79M	US#2,356/3,121 Sec#194/266
Current Ratio	6.06x	US#391/3,121 Sec#124/266
Net Debt/EBITDA	1.32x	US#1,092/3,121 Sec#49/266
Performance
1Y Return	198.63%	US#52/3,121 Sec#21/266
1M Return	0.00%	US#1,189/3,121 Sec#110/266
From 52W High	-24.57%	US#1,880/3,121 Sec#143/266
1Y MDD	-43.60%	US#2,189/3,121 Sec#156/266
Trading
Volume	7,019,407 shares	US#629/3,121 Sec#61/266
Trading Value	$30M	US#2,223/3,121 Sec#181/266
Per Share
EPS	$0.79	US#1,757/3,121 Sec#51/266
BPS	$-0.98	US—/3,121 Sec—/266